BACKGROUND: Atopic dermatitis leads to epidermal barrier dysfunction and bacteria colonization. The relationship of the last factor with the severity of the disease and the frequency of exacerbation is not fully known. OBJECTIVES: Verify the severity of the atopic dermatitis and the number of appointments generated by dermatosis, comparing patients colonized with patients not colonized by S. aureus. Verify the frequency of colonization by methicillin resistant Staphylococcus aureus acquired in the community. METHODS: Cohort study with a 12 months follow-up, in a sample of patients from Porto Alegre, RS public network. Cultures in active injuries and nasal cavities were carried out as well as methicillin sensitivity tests to S. aureus. The severity of atopic dermatitis was defined by Eczema Area and Severity Index (EASI). RESULTS: We included 93 patients, 43% female and 56% male, 26 colonized by S. aureus in the nasal orifices, 56 in the skin damage. The mean of initial Eczema Area and Severity Index was 5.5 and final 3.9. The initial Eczema Area and Severity Index of patients colonized by S. aureus in the skin and nasal cavity was larger than the number of patients without colonization(p< 0.05). During the period of one year, in average, there were six appointments/patient. There was linear correlation between the number of appointments during one year and the inicial Eczema Area and Severity Index (r = 0,78). There were no patients with methicillin resistant Staphylococcus aureus acquired in the community. CONCLUSION: There is a relevant influence of staphylococcal colonization on the severity of atopic dermatitis and the number of appointments required by its exacerbation. Methicillin resistance among those affected by S. aureus does not seem to be an emergent problem, in this Brazilian sample.
BACKGROUND:Atopic dermatitis leads to epidermal barrier dysfunction and bacteria colonization. The relationship of the last factor with the severity of the disease and the frequency of exacerbation is not fully known. OBJECTIVES: Verify the severity of the atopic dermatitis and the number of appointments generated by dermatosis, comparing patients colonized with patients not colonized by S. aureus. Verify the frequency of colonization by methicillin resistant Staphylococcus aureus acquired in the community. METHODS: Cohort study with a 12 months follow-up, in a sample of patients from Porto Alegre, RS public network. Cultures in active injuries and nasal cavities were carried out as well as methicillin sensitivity tests to S. aureus. The severity of atopic dermatitis was defined by Eczema Area and Severity Index (EASI). RESULTS: We included 93 patients, 43% female and 56% male, 26 colonized by S. aureus in the nasal orifices, 56 in the skin damage. The mean of initial Eczema Area and Severity Index was 5.5 and final 3.9. The initial Eczema Area and Severity Index of patients colonized by S. aureus in the skin and nasal cavity was larger than the number of patients without colonization(p< 0.05). During the period of one year, in average, there were six appointments/patient. There was linear correlation between the number of appointments during one year and the inicial Eczema Area and Severity Index (r = 0,78). There were no patients with methicillin resistant Staphylococcus aureus acquired in the community. CONCLUSION: There is a relevant influence of staphylococcal colonization on the severity of atopic dermatitis and the number of appointments required by its exacerbation. Methicillin resistance among those affected by S. aureus does not seem to be an emergent problem, in this Brazilian sample.
Atopic Dermatitis (AD) is characterized as a chronic inflammatory skin disease related
to genetic changes in the proteins that support the epidermal barrier and associated
with asthma and rhinitis. [1]In general, AD affects approximately 5-20% of children and 1-3% of adults and in spite
of a very low risk of death, it has a high impact in terms of morbidity and on the
quality of life of patients. [2,3]ADpatients are at increased risk of developing bacterial colonization, especially
staphylococcal. [4,5] The Staphylococcus aureus (S. aureus)
can be isolated in skin lesions in 76-100% of cases and may be involved in the
exacerbation of AD. [6-10]The effect attributed to colonization leads to attempts to suppress bacterial growth in
the management of AD. On the other hand, due to documented cutaneous infection
susceptibility, ADpatients require more frequent use of topical and systemic
antibiotics, which can lead to the development of greater microbial resistance in this
population and the resulting colonization by new microorganisms, such as MRSA
(methicillin resistant Staphylococcus aureus). [11]Nevertheless, there have not been studies in Brazil demonstrating the association
between staphylococcal colonization in ADpatients and a higher frequency and/or an
increased severity of exacerbations.The present study was developed because of the known variability of bacterial
colonization in patients with AD, recognizing the importance of having more knowledge
about microbiological epidemiology, which may assist in the care of these patients.Our objectives were to verify, in patients with AD, the prevalence of staphylococcal
colonization and CA-MRSA (methicillin resistant Staphylococcus aureus
in the community), the severity of dermatosis in patients colonized by
S. aureus and the effects of this colonization on the number of
consultations over a year of monitoring.
MATERIALS AND METHODS
The study was approved by the Research Ethics Committee of the Federal University of
Health Sciences of Porto Alegre and the School of Public Health of Rio Grande do Sul,
Brazil.It is a prospective cohort study of one year duration for each patient. During the years
2010 and 2011, 93 patients diagnosed with AD who attended the Dermatology Service at the
Federal University of Health Sciences of Porto Alegre and the Dermatology Health Clinic
of the State of Rio Grande do Sul were monitored.The study included ADpatients with the diagnosis made in accordance with Hanifin's and
Rajka's criteria. [12] The study
excluded patients with criteria for hospital acquired MRSA, and those who were using
systemic antibiotics at the time or period of one month prior to consultation, and/or
using topical antibiotics at the time or within 15 days prior to the consultation and
also patients colonized by other microorganisms. All of the study participants, or their
legal guardians, signed an informed consent term.Samples were obtained by collecting a swab of AD skin lesion and of uninfected nasal
cavity. The severity score used was the EASI (Eczema Area and Severity Index), validated
internationally. [12]Procedures for microbiological identification were carried out by phenotypic tests for
characterization of Staphylococcus sp (Gram stain, colony morphology,
fermentation of mannitol salt agar); by further tests (catalase, coagulase, DNAse); by
antimicrobial susceptibility tests (Difco and D-diffusion test) and genotypic tests (PCR
for detection of gene mec A, multiplex PCR to determine the type of SCCmec, PCR
detection lukF gene, encoding the PVL polymorphism analysis of chromosomal DNA).Each patient was followed for 12 months regarding the number of new consultations due to
the exacerbation of AD. The EASI was applied at the first visit and again after one
year. The median of the cases was found for comparison purposes.To measure the significance of the results, the statistical test of Bartlett's was
used.
RESULTS
The variables and the demographic characteristics relating to the study sample are shown
in table 1.
TABLE 1
Factors evaluated in patients with Atopic Dermatitis, n=93
Factors
N=93
Age
2.5 years (mean)
Sex
51 (54.8%) / 42 (45.2%)
Colonization by S. aureus in the skin damage
26 patients (%)
Nasal colonization by S. aureus
56 patients (%)
Initial EASI
5.5 (median)
Final EASI
3.9 (median)
Number of appointments during 12 months
6 (median)
Factors evaluated in patients with Atopic Dermatitis, n=93Ninety-three patients were followed, with approximately 45.2% female and 54.8% male. In
terms of age, the average was 2.5 years old; about 13% were infants (0-21 months), 72%
were preschool to school (2-11 years), 11.6% were teenagers and young adults (12-29
years) and 1.1% were adults over 30 years.The initial EASI of the patients showed a median of 5.5 (with minimum 0.4 and maximum
40.5), and a final median EASI 3.9 (minimum of zero and a maximum of 56.8).Regarding the number of consultations after 12 months, a median of 6 was shown, with a
minimum of three visits and a maximum of 17 appointments.In relation to the colonization by S. aureus, among the 93 patients, 26
and 56 were colonized, respectively, in skin lesions (SAL) and in the nasal passages
(SAN). In total, 64 patients (68.8%) were colonized, considering the nasal cavity and /
or skin. CA-MRSA was not detected in the samples.Colonized patients were compared with those not colonized at the initial severity
(EASI).Graph 1 shows that SAL patients have an EASI
higher when compared to those who were not colonized, the result being statistically
significant (p = 0.0212).
GRAPH 1
Initial EASI and colonization by S. aureus in the skin damage
Initial EASI and colonization by S. aureus in the skin damageGraph 2 shows the comparison of SAN patients in
relation to non colonized (p = 0.0059).
GRAPH 2
Initial EASI and colonization by S. aureus in the nasal
cavities
Initial EASI and colonization by S. aureus in the nasal
cavitiesGraph 3 shows the linear correlation (r) between
the number of consultations in one year and the EASI, where the correlation coefficient
is relevant, r = 0.78. (0.5 ≤ r <0.8).
GRAPH 3
Correlation between EASI and the number of appointments
Correlation between EASI and the number of appointments
DISCUSSION
AD is among the most common chronic inflammatory skin dermatoses in childhood. Thus, in
accordance with several studies from different countries, this study carried out in
southern Brazil showed a higher frequency of dermatoses in children (11 years) compared
to other age groups, with an average age of 2.5 years.Skin colonization with S. aureus among patients with AD is common,
particularly in skin lesions and in the nasal passages. Our study also found a
significant prevalence of staphylococcal colonization.The results showed a direct association between the initial severity (EASI) and the
presence of nasal bacteria (p = 0.0059). This finding confirms the evidence already
described in other publications. A cohort from 2009 showed that Dutch children with
positive nasal colonization by S. aureus at 6 months of age not only
had a higher risk of developing AD, but also an increased risk of moderate to severe AD,
compared to non carriers. [13]Likewise, in this study, patients with positive S. aureus in AD lesions
were more severely affected than those without the bacteria, the results being
statistically significant (p = 0.021).Some studies have found an increasing proportion of MRSA in individuals with AD,
including that of Nishijima et al, who documented an increase from 34.2% to 41.5% in a
period of three years. Another study, from 2008, comprising 54 patients with AD from a
hospital in Philadelphia (USA), showed a high colonization by S. aureus
(80%) but isolated MRSA in only seven (16%).[5]In our research with this sample from southern Brazil a growth of CA-MRSA was not
noticed in cultures, demonstrating a particular microbiological and epidemiological
overview.The present study showed a strong linear correlation (r = 0.78) between the EASI and the
initial number of consultations within a year, as shown in graph 3, with a clear trend to increased frequency of consultations
linked to the higher initial EASI; the most severe cases tend to return more times in
one year, compared with less severe ones.
CONCLUSION
This sample of southern Brazil showed 68.8% of colonization by S. aureus in patients
with AD; there was greater severity of AD and a higher number of consultations due to
exacerbation of the disease among those colonized by S. aureus.CA-MRSA colonization was not a major problem in this sample from southern Brazil, during
the study period.
Authors: Jon M Hanifin; Kevin D Cooper; Vincent C Ho; Sewon Kang; Bernice R Krafchik; David J Margolis; Lawrence A Schachner; Robert Sidbury; Susan E Whitmore; Carol K Sieck; Abby S Van Voorhees Journal: J Am Acad Dermatol Date: 2004-03 Impact factor: 11.527
Authors: Michael J Cork; Darren A Robinson; Yiannis Vasilopoulos; Adam Ferguson; Manar Moustafa; Alice MacGowan; Gordon W Duff; Simon J Ward; Rachid Tazi-Ahnini Journal: J Allergy Clin Immunol Date: 2006-06-09 Impact factor: 10.793
Authors: Ankie Lebon; Joost A M Labout; Henri A Verbrugh; Vincent W V Jaddoe; Albert Hofman; Willem J B van Wamel; Alex van Belkum; Henriëtte A Moll Journal: Arch Pediatr Adolesc Med Date: 2009-08
Authors: Eric L Simpson; Miguel Villarreal; Brett Jepson; Nick Rafaels; Gloria David; Jon Hanifin; Patricia Taylor; Mark Boguniewicz; Takeshi Yoshida; Anna De Benedetto; Kathleen C Barnes; Donald Y M Leung; Lisa A Beck Journal: J Invest Dermatol Date: 2018-03-28 Impact factor: 8.551
Authors: Sandrine Blanchet-Réthoré; Valérie Bourdès; Annick Mercenier; Cyrille H Haddar; Paul O Verhoeven; Philippe Andres Journal: Clin Cosmet Investig Dermatol Date: 2017-07-03